From 1 April 2020, new requirements for indicating the country of origin or place of provenance of the primary ingredient on the label apply. Doubts and problems of interpretation related to this have been discussed by Marta Łanoch in the quarterly “World of the Pharmaceutical Industry”. Those interested are invited to read the article.
